40 research outputs found

    New perspectives in human movement variability

    Get PDF
    Movement variability is defined as the normal variations that occur in motor performance across multiple repetitions of a task.2 Bernstein1 described movement variability quite eloquently as ‘‘repetition without repetition.’’ Traditionally, movement variability has been linked to noise and error, being considered to be random and independent. This theoretical approach blends well with traditional statistical and assessment methods of movement variability that assume randomness and independence of observations. However, numerous studies have indicated that when movement is observed over time variations are closely related with each other neither being random nor independent. Practically, traditional methods can mask the temporal structure of movement variability and contain little information about how movement changes over time

    ARWalker: A Virtual Walking Companion Application

    Full text link
    Extended Reality (XR) technologies, including Augmented Reality (AR), have attracted significant attention over the past few years and have been utilized in several fields, including education, healthcare, and manufacturing. In this paper, we aim to explore the use of AR in the field of biomechanics and human movement through the development of ARWalker, which is an AR application that features virtual walking companions (avatars). Research participants walk in close synchrony with the virtual companions, whose gait exhibits properties found in the gait of young and healthy adults. As a result, research participants can train their gait to the gait of the avatar, thus regaining the healthy properties of their gait and reducing the risk of falls. ARWalker can especially help older adults and individuals with diseases, who exhibit pathological gait thus being more prone to falls. We implement a prototype of ARWalker and evaluate its systems performance while running on a Microsoft Hololens 2 headset

    A Nonlinear Analysis Software Toolkit for Biomechanical Data

    Full text link
    In this paper, we present a nonlinear analysis software toolkit, which can help in biomechanical gait data analysis by implementing various nonlinear statistical analysis algorithms. The toolkit is proposed to tackle the need for an easy-to-use and friendly analyzer for gait data where algorithms seem complex to implement in software and execute. With the availability of our toolkit, people without programming knowledge can run the analysis to receive human gait data analysis results. Our toolkit includes the implementation of several nonlinear analysis algorithms, while it is also possible for users with programming experience to expand its scope by implementing and adding more algorithms to the toolkit. Currently, the toolkit supports MatLab bindings while being developed in Python. The toolkit can seamlessly run as a background process to analyze hundreds of different gait data and produce analysis outcomes and figures that illustrate these results

    Age induced modifications in the persistency of voluntary sway when actively tracking the complex motion of a visual target

    Get PDF
    Movement persistency, reflected in systematic cycle to cycle fluctuations of a rhythmical task such as walking or voluntary sway, is compromised with increasing age, making older adults more susceptible to falls. In the present study, we tested whether it is possible to improve rhythmic voluntary sway persistency in old age by actively tracking the complex (i.e. persistent) motion of a visual target. Twenty healthy young and 20 older adults performed 132 cycles of anterior-posterior sway under two conditions: a) self-paced sway and b) sway while tracking the vertical motion of a complex visual target. The persistency of sway cycle amplitude and duration, detected from the center of pressure displacement, was quantified using the Fractal exponent α. We also recorded body kinematics in order to assess the intersegmental coordination that was quantified in the Mean Absolute Relative Phase (MARP) and the Deviation Phase (DPh) between the trunk and the lower limbs. In self-paced sway, older adults showed a lower persistency of cycle duration and a higher MARP and DPh between the trunk and the lower limbs compared to young adults. Tracking the complex visual target motion increased the persistency of cycle amplitude, in young but not in older adults, when compared to the self-paced sway while it decreased the persistency of cycle duration in both groups. The relative phase measures showed a moderate to strong relationship with the persistency of cycle amplitude and duration when older adults swayed in their self-pace. These findings suggest older adults cannot exploit active tracking of the complex visual motion cue to improve voluntary sway persistency. This could be related to the less stable and out of phase intersegmental coordination characterizing rhythmic voluntary sway in old age

    Mastoid vibration affects dynamic postural control during gait in healthy older adults

    Get PDF
    Vestibular disorders are difficult to diagnose early due to the lack of a systematic assessment. Our previous work has developed a reliable experimental design and the result shows promising results that vestibular sensory input while walking could be affected through mastoid vibration (MV) and changes are in the direction of motion. In the present paper, we wanted to extend this work to older adults and investigate how manipulating sensory input through mastoid vibration (MV) could affect dynamic postural control during walking. Three levels of MV (none, unilateral, and bilateral) applied via vibrating elements placed on the mastoid processes were combined with the Locomotor Sensory Organization Test (LSOT) paradigm to challenge the visual and somatosensory systems. We hypothesized that the MV would affect sway variability during walking in older adults. Our results revealed that MV significantly not only increased the amount of sway variability but also decreased the temporal structure of sway variability only in anterior-posterior direction. Importantly, the bilateral MV stimulation generally produced larger effects than the unilateral. This is an important finding that confirmed our experimental design and the results produced could guide a more reliable screening of vestibular system deterioration

    The Rim and the Ancient Mariner: The Nautical Horizon Affects Postural Sway in Older Adults

    Get PDF
    On land, the spatial magnitude of postural sway (i.e., the amount of sway) tends to be greater when participants look at the horizon than when they look at nearby targets. By contrast, on ships at sea, the spatial magnitude of postural sway in young adults has been greater when looking at nearby targets and less when looking at the horizon. Healthy aging is associated with changes in the movement patterns of the standing body sway, and these changes typically are interpreted in terms of age-related declines in the ability to control posture. To further elucidate the mechanisms associated with these changes we investigated control of posture in a setting that poses substantial postural challenges; standing on a ship at sea. In particular, we explored postural sway on a ship at sea when older adults looked at the horizon or at nearby targets. We evaluated the kinematics of the center of pressure in terms of spatial magnitude (i.e., the amount of sway) and multifractality (a measure of temporal dynamics). We found that looking at the horizon significantly affected the multifractality of standing body, but did not systematically influence the spatial magnitude of sway. We discuss the results in terms of age-related changes in the perception and control of dynamic body orientation

    Motor control of the lower extremity musculature in children with cerebral palsy

    Get PDF
    The aim of this investigation was to quantify the differences in torque steadiness and variability of the muscular control in children with cerebral palsy (CP) and typically developing (TD) children. Fifteen children with CP (age = 14.2 ± 0.7 years) that had a Gross Motor Function Classification System (GMFCS) score of I-III and 15 age and gender matched TD children (age = 14.1 ± 0.7 years) participated in this investigation. The participants performed submaximal steady-state isometric contractions with the ankle, knee, and hip while surface electromyography (sEMG) was recorded. An isokinetic dynamometer was used to measure the steady-state isometric torques while the participants matched a target torque of 20% of the subject’s maximum voluntary torque value. The coefficient of variation was used to assess the amount of variability in the steady-state torque, while approximate entropy was used to assess the regularity of the steady-state torque over time. Lastly, the distribution of the power spectrum of the respective sEMG was evaluated. The results of this investigation were: 1) children with CP had a greater amount of variability in their torque steadiness at the ankle than TD children, 2) children with CP had a greater amount of variability at the ankle joint than at the knee and hip joint, 3) the children with CP had a more regular steady-state torque pattern than TD children for all the joints, 4) the ankle sEMG of children with CP was composed of higher harmonics than that of the TD children

    The Changing Landscape for Stroke\ua0Prevention in AF: Findings From the GLORIA-AF Registry Phase 2

    Get PDF
    Background GLORIA-AF (Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation) is a prospective, global registry program describing antithrombotic treatment patterns in patients with newly diagnosed nonvalvular atrial fibrillation at risk of stroke. Phase 2 began when dabigatran, the first non\u2013vitamin K antagonist oral anticoagulant (NOAC), became available. Objectives This study sought to describe phase 2 baseline data and compare these with the pre-NOAC era collected during phase 1. Methods During phase 2, 15,641 consenting patients were enrolled (November 2011 to December 2014); 15,092 were eligible. This pre-specified cross-sectional analysis describes eligible patients\u2019 baseline characteristics. Atrial fibrillation disease characteristics, medical outcomes, and concomitant diseases and medications were collected. Data were analyzed using descriptive statistics. Results Of the total patients, 45.5% were female; median age was 71 (interquartile range: 64, 78) years. Patients were from Europe (47.1%), North America (22.5%), Asia (20.3%), Latin America (6.0%), and the Middle East/Africa (4.0%). Most had high stroke risk (CHA2DS2-VASc [Congestive heart failure, Hypertension, Age  6575 years, Diabetes mellitus, previous Stroke, Vascular disease, Age 65 to 74 years, Sex category] score  652; 86.1%); 13.9% had moderate risk (CHA2DS2-VASc = 1). Overall, 79.9% received oral anticoagulants, of whom 47.6% received NOAC and 32.3% vitamin K antagonists (VKA); 12.1% received antiplatelet agents; 7.8% received no antithrombotic treatment. For comparison, the proportion of phase 1 patients (of N = 1,063 all eligible) prescribed VKA was 32.8%, acetylsalicylic acid 41.7%, and no therapy 20.2%. In Europe in phase 2, treatment with NOAC was more common than VKA (52.3% and 37.8%, respectively); 6.0% of patients received antiplatelet treatment; and 3.8% received no antithrombotic treatment. In North America, 52.1%, 26.2%, and 14.0% of patients received NOAC, VKA, and antiplatelet drugs, respectively; 7.5% received no antithrombotic treatment. NOAC use was less common in Asia (27.7%), where 27.5% of patients received VKA, 25.0% antiplatelet drugs, and 19.8% no antithrombotic treatment. Conclusions The baseline data from GLORIA-AF phase 2 demonstrate that in newly diagnosed nonvalvular atrial fibrillation patients, NOAC have been highly adopted into practice, becoming more frequently prescribed than VKA in Europe and North America. Worldwide, however, a large proportion of patients remain undertreated, particularly in Asia and North America. (Global Registry on Long-Term Oral Antithrombotic Treatment in Patients With Atrial Fibrillation [GLORIA-AF]; NCT01468701
    corecore